Endocrinology

The Lipid Disorders Specialty Group provides a multidisciplinary approach to the diagnosis and treatment of lipid disorders, including access to specialized diagnostic tests including:

• Genetic testing for familial hypercholesterolemia (FH)
• Apolipoprotein E (ApoE) genotype
• Lipoprotein(a)
• Apoproteins
• C-reactive protein assays

Access to specialized treatments is available for severe dyslipidemia such as apheresis and novel lipid lowering drugs such as PCSK9 inhibitors. Providers collaborate with registered dietitians to provide a comprehensive approach to dyslipidemia management.

Adults and children referred to the Lipid Disorders Specialty Group typically have symptoms or conditions that include:

• Suspected genetic lipid disorders: a strong family history of dyslipidemia or LDL cholesterol greater than 190 mg/dL or triglycerides greater than 1,000 mg/dL
• Cholesterol or triglyceride elevations that don't respond to the usual treatment, when combination drug treatment is required
• Very low total cholesterol (less than 100 mg/dL)
• Secondary dyslipidemia due to diabetes mellitus or renal disease
• Organ transplant and dyslipidemia
• Premature cardiovascular disease
• Strong family history of premature cardiovascular disease
• Suspected lipodystrophy or other disorders of body fat distribution